Affimed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Affimed and other ETFs, options, and stocks.

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. 

CEO
Shawn M. Leland
CEOShawn M. Leland
Employees
78
Employees78
Headquarters
Mannheim, Baden Wuerttemberg
HeadquartersMannheim, Baden Wuerttemberg
Founded
2000
Founded2000
Employees
78
Employees78

AFMD Key Statistics

Market cap
4.19M
Market cap4.19M
Price-Earnings ratio
-0.08
Price-Earnings ratio-0.08
Dividend yield
Dividend yield
Average volume
94.75M
Average volume94.75M
High today
$0.5731
High today$0.5731
Low today
$0.0815
Low today$0.0815
Open price
$0.1838
Open price$0.1838
Volume
919.29M
Volume919.29M
52 Week high
$8.95
52 Week high$8.95
52 Week low
$0.0701
52 Week low$0.0701

People also own

Based on the portfolios of people who own AFMD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.